Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Leiomyoma × Tea × Clear all

Phase

Phase 3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 2 Stomach Neoplasms 1 Psychological Well-Being 1 Pancreatic Neoplasms 1 Motor Activity 1 Lung Neoplasms 1 Liver Neoplasms 1 Leiomyoma 1 Inflammation 1 Esophageal Neoplasms 1 Agnosia 1 Abdominal Cancer 1

Interventions

vilaprisan 6 asoprisnil 6 ulipristal acetate 5 telapristone acetate 5 relugolix 5 estradiol, norethindrone drug combination 5 elagolix 4 Estradiol 4 linzagolix 3 Norethindrone Acetate 3 Progestins 2 epigallocatechin gallate 1 Uterine Myomectomy 1 Uterine Artery Embolization 1 Tranexamic Acid 1 Tea 1 Sugars 1 Standard of Care 1 Sodium Chloride 1 Misoprostol 1 Mifepristone 1 Megestrol Acetate 1 Medroxyprogesterone Acetate 1 Leuprolide 1 Laparoscopy 1 Iron 1 Hysterectomy 1 Goserelin 1 Gonadotropin-Releasing Hormone 1 Dexamethasone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05364008 2025-07-25

FRIEND

Yale University

Phase 3 Recruiting

Leiomyoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡